Current status and future prospects of p38α/MAPK14 kinase and its inhibitors

MM Madkour, HS Anbar, MI El-Gamal - European journal of medicinal …, 2021 - Elsevier
P38α (which is also named MAPK14) plays a pivotal role in initiating different disease states
such as inflammatory disorders, neurodegenerative diseases, cardiovascular cases, and …

Clinically precedented protein kinases: Rationale for their use in neurodegenerative disease

CL Benn, LA Dawson - Frontiers in Aging Neuroscience, 2020 - frontiersin.org
Kinases are an intensively studied drug target class in current pharmacological research as
evidenced by the large number of kinase inhibitors being assessed in clinical trials. Kinase …

Function and inhibition of P38 MAP kinase signaling: Targeting multiple inflammation diseases

J Wang, Y Liu, Y Gu, C Liu, Y Yang, X Fan… - Biochemical …, 2023 - Elsevier
Inflammation is a natural host defense mechanism that protects the body from pathogenic
microorganisms. A growing body of research suggests that inflammation is a key factor in …

Discovery of druggable potent inhibitors of serine proteases and farnesoid X receptor by ligand-based virtual screening to obstruct SARS-CoV-2

S Zaib, N Rana, HS Ali, N Hussain, HA Ogaly… - International Journal of …, 2023 - Elsevier
The coronavirus, a subfamily of the coronavirinae family, is an RNA virus with over 40
variations that can infect humans, non-human mammals and birds. There are seven types of …

The p38 MAPK inhibitors and their role in inflammatory diseases

TR Machado, TR Machado, PG Pascutti - ChemistrySelect, 2021 - Wiley Online Library
The p38 family is a highly evolutionarily conserved group of mitogen‐activated protein
kinases (MAPKs) that is involved in and helps co‐ordinate cellular responses to nearly all …

1, 4-Benzodioxane, an evergreen, versatile scaffold in medicinal chemistry: A review of its recent applications in drug design

C Bolchi, F Bavo, R Appiani, G Roda… - European Journal of …, 2020 - Elsevier
Benzodioxane has long been a versatile template widely employed to design molecules
endowed with diverse bioactivities. Its use spans the last decades of medicinal chemistry …

Identification of potent inhibitors targeting EGFR and HER3 for effective treatment of chemoresistance in non-small cell lung cancer

AA Dera, S Zaib, Areeba, N Hussain, N Rana, H Javed… - Molecules, 2023 - mdpi.com
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer. Despite the
existence of various therapeutic options, NSCLC is still a major health concern due to its …

Q-raKtion: a semiautomated KNIME workflow for bioactivity data points curation

D Palazzotti, M Fiorelli, S Sabatini… - Journal of Chemical …, 2022 - ACS Publications
The recent increase of bioactivity data freely available to the scientific community and stored
as activity data points in chemogenomic repositories provides a huge amount of ready-to …

Identification of anti-influenza A compounds inhibiting the viral non-structural protein 1 (NS1) using a type I interferon-driven screening strategy

G Marsili, C Acchioni, AL Remoli, D Amatore… - International Journal of …, 2023 - mdpi.com
There is an urgent need to identify efficient antiviral compounds to combat existing and
emerging RNA virus infections, particularly those related to seasonal and pandemic …

From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for …

A Astolfi, F Milano, D Palazzotti, J Brea, MC Pismataro… - Pharmaceutics, 2022 - mdpi.com
Acute myeloid leukemia (AML) is a heterogeneous hematopoietic malignancy whose
prognosis is globally poor. In more than 60% of AML patients, the PI3K/AKTs/mTOR …